Table 1.

Characteristics of 919 participants including anthropometric characteristics, pancreatic abnormalities, lifestyle-related diseases, glucose and lipid profiles, and hepatic abnormalities.

	Normal pancreas	Fatty pancreas
	(n = 489)	(n = 430)	P value
Age, yrs	57.4 ± 14.0	61.8 ± 11.7	<.001
Sex, males/females (n)	227/262	272/158	<.001
Weight, kg	57.4 ± 11.1	67.9 ± 12.8	<.001
BMI	21.8 ± 3.0	25.4 ± 3.5	<.001
Waist circumference, cm	80.1 ± 8.4	90.5 ± 8.5	<.001
Pancreatic abnormalities
Amylase, U/L	86.9 ± 28.2	76.6 ± 25.7	<.001
Lipase, U/L	33.5 ± 15.5	32.5 ± 23.8	.318
Brightness score of pancreas	88.6 ± 16.0	130.8 ± 14.3	<.001
Pancreatic cyst (%)	5.6	4.9	.762
Life style-related diseases
Hypertention (%)	7.8	12.1	.034
Diabetes mellitus (%)	5.1	15.8	<.001
Dyslipidemia (%)	27.8	48.6	<.001
Metabolic syndrome (%)	12.7	50.2	<.001
Frequency of alcohol intake 0/1/2	249/149/91	209/107/114	.010
Amount of alcohol intake 0/1/2	364/85/31	285/81/58	.001
Gallbladder stones (%)	4.5	11.2	<.001
Glucose metabolism and lipid profiles
FPG, mg/dL	99.2 ± 13.3	106.4 ± 19.1	<.001
HbA1c, %	5.6 ± 0.4	5.9 ± 0.6	<.001
HDL-C, mg/dL	67.4 ± 17.1	57.8 ± 14.2	<.001
LDL-C, mg/dL	117.2 ± 29.5	123.7 ± 28.0	.001
TG, mg/dL	91.5 ± 58.4	129.1 ± 123.2	<.001
Triglyceride and glucose (TyG) index	8.3 ± 0.5	8.7 ± 0.6	<.001
Hepatic abnormalities
Steatosis grade by US 0/1/2/3	421/20/22/26	184/51/54/141	<.001
Platelet, ×1010/L	22.7 ± 5.0	22.9 ± 6.0	.132
Albumin, g/dL	4.4 ± 0.3	4.4 ± 0.3	.126
AST, U/L	22.7 ± 7.7	25.6 ± 10.6	<.001
ALT, U/L	19.7 ± 11.6	27.2 ± 18.3	<.001
ALP, U/L	202.7 ± 65.1	218.1 ± 64.7	.005
γ-GT, U/L	30.3 ± 43.6	41.1 ± 38.4	<.001
Fib-4 index	1.43 ± 0.76	1.47 ± 0.68	<.001
Hepatic steatosis index (HSI)	29.8 ± 4.2	34.6 ± 5.5	<.001
Others
CRP, mg/dL	0.1 ± 0.4	0.1 ± 0.2	.702